COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Also, Scripps does not provide COVID-19 tests for asymptomatic patients. See FAQs.
Investigational Drug for Advanced or Metastatic Solid Tumor Cancers
Darren Sigal, M.D.
This study will test the safety and effectiveness of OBI-999 (investigational study drug), given once every three weeks via intravenous infusion (IV) in patients with locally advanced or metastatic solid tumor cancer.
Be 18 years of age or older
Be ambulatory and able to carry out work of a light or sedentary nature.
Have a tissue specimen from a prior biopsy to be submitted for Globo-H analysis
Patients must not:
Be pregnant or nursing
Be taking immunosuppressive therapies (i.e._cyclosporine, rapamycin, tacrolimus, cyclophosphamide, or methotrexate) or require daily systemic steroids of >10 mg/day
Have a history of solid organ transplant
Have known untreated central nervous system disease
All physician visits and study treatments will occur at Scripps Clinic Torrey Pines (Geisel Pavilion).
Study treatment is given once every three weeks by intravenous infusion (IV).
Search for NCT04084366 on https://clinicaltrials.gov/ for additional information.